Trials / Recruiting
RecruitingNCT05497024
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 45 (estimated)
- Sponsor
- M.D. Anderson Cancer Center · Academic / Other
- Sex
- Male
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
This protocol describes development and user testing of an educational shared decision making intervention to help men with prostate cancer who are on active surveillance make decisions with their health care providers about if and when to de-escalate surveillance testing. The project is important because for many patients their cancer does not progress to the point of needed curative treatment or their health status changes such that they are no longer good candidates for treatment. For these men, de-escalating ongoing surveillance (e.g., fewer biopsies or imaging studies) is a reasonable option.
Detailed description
Objectives: The overall goal of this protocol is to develop and refine an educational tool for use by patients and health-care providers to help men with localized prostate cancer make informed decisions about discontinuation of active surveillance. * Conduct cognitive and initial usability and acceptability testing of a prototype decision aid with patients * Conduct cognitive and initial usability and acceptability testing of a prototype decision aid with care partners/caregivers * Conduct expert reviews of a prototype decision aid with clinicians
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Interviews | Participants will discuss background, such as race, education, and living situation. Participants will discuss Prostate cancer Participants will discuss feedback on the educational material |
| BEHAVIORAL | Surveys | Participants may answer questions that are sensitive in nature. |
Timeline
- Start date
- 2022-08-15
- Primary completion
- 2027-02-02
- Completion
- 2027-02-02
- First posted
- 2022-08-11
- Last updated
- 2026-04-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05497024. Inclusion in this directory is not an endorsement.